Replies to post #110722 on Biotech Values

[drbio45]

Harry Stylli as restructuring chief and Mark Attarian as interim financial chief.

harry stylli can turn stocks aroound. he recapped sequenom and the stock went from the two to the twenty's based on false data.

How can he be in charge of turning around another company, even if he had nothing to do with the scam at sequenom he was running the company and should have had procedures in place to prevent that scam was taking place.

[DewDiligence]

Recent Biotech Bankruptcies

[Added MIPI]

 
          Filing  iHub 
 Company   Date   Reference 
 AGIX     10/08   #msg-31947587 
 ALTU     11/09   #msg-43509933 
 AMB.TO    8/09   #msg-40145970 
 ANSV      1/10   #msg-45161615 
 ARTE     12/08   #msg-33895436 
 BPUR      7/09   #msg-39629524 
 CJB.TO    7/10   #msg-52557510 
 CLSC      8/09   #msg-40685152 
 CHKT     12/08   #msg-33949508 
 DCGN     11/09   #msg-43629379 
 ILE       6/09   #msg-38746197 
 INGN     12/08   #msg-33947783 
 GTOP      9/08   #msg-32249160 
 MBRK      4/10   #msg-49658072 
 MIIS     11/08   #msg-33720220 
 MIPI     12/10   #msg-57646943 
 OSCI      7/09   #msg-39511719 
 REX      11/08   #msg-32189097 
 TPPH      2/08   #msg-26765260 
 VION     12/09   #msg-44654555 
 VRA      10/07   #msg-18053275